Medical Procedure News

RSS

BioMimetic reports final study results comparing Augment Bone Graft to autograft in foot, ankle fusion surgery

BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.

8 Jul 2010

Review examines surgical and non-surgical treatments available for patients with knee arthritis

Middle-aged men and women with osteoarthritis of the knee now have more options than ever before for treatments that may allow them to remain active in the sports they love, according to a review published in the July 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons.

8 Jul 2010

FDA issues formal response to Nephros' 510(k) application for hemodiafiltration system

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.

8 Jul 2010

Robots help remove diseased thyroid gland without neck incision

Robots that revolutionized gynecologic and urologic surgery in the past decade now offer the option of removing at least a portion of their diseased thyroid gland without the hallmark neck incision, researchers said.

7 Jul 2010

AUGIB patients more likely to suffer further bleeding with early red blood cell transfusion

Doctors have called for an urgent review of transfusion policies after a UK-wide study of over 200 hospitals found that patients admitted with acute upper gastrointestinal bleeding (AUGIB) are more than twice as likely to suffer further bleeding if they receive a red blood cell transfusion within 12 hours.

7 Jul 2010

Capstone Therapeutics to continue AZX100 Phase 2a trial in dermal scarring to planned 12-month endpoints

Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.

7 Jul 2010

New Center for Image-Guided Intervention opened at MSKCC

Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.

7 Jul 2010

Medicare reimbursement rates for outpatient repair of anal fistulas increased by 6%

Hospitals nationwide will receive six percent higher reimbursement payments for outpatient repair of anal fistulas using Cook Medical's Biodesign® Fistula Plug, a device designed specifically to treat this painful and embarrassing disorder of the lower GI tract. According to new Medicare payment schedules effective January 1st, hospital outpatient surgery departments will receive approximately $2,200 per procedure, while freestanding ambulatory surgery centers will be paid about $1,300 on average.

7 Jul 2010

Aastrom to pursue Phase 3 CLI clinical program through FDA SPA process

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.

7 Jul 2010

FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations

Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.

7 Jul 2010

Hope for ovarian cancer patients not responding to conventional chemotherapy

Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

6 Jul 2010

AHRQ publishes new comparative effectiveness report on treatments for rotator cuff tears

Injuries to the rotator cuff are treatable, but it is unclear which treatment option - surgery or nonsurgical treatments such as exercise or medication - is best, according to a new comparative effectiveness report published by HHS' Agency for Healthcare Research and Quality.

6 Jul 2010

Music therapy improves movement in stroke patients

Music therapy provided by trained music therapists may help to improve movement in stroke patients, according to a new Cochrane Systematic Review. A few small trials also suggest a wider role for music in recovery from brain injury.

6 Jul 2010

First Australian intestinal transplant

Mr. Brendan Cole, 32 became the first recipient of a successful intestinal transplant in Australia. Last Friday he had his intestines and organs removed from his abdomen that followed a 12 hour operation at Austin Health.

4 Jul 2010

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons.

3 Jul 2010

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

From Elekta 3 Jul 2010

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

European legislation that requires all couples undergoing assisted reproduction treatment (ART) to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing for patients, the 26th annual meeting of the European Society of Human Reproduction and Embryology heard Monday.

2 Jul 2010

Imaging algorithm distributed in top-down fashion reduces unnecessary cervical spine radiographs

An imaging algorithm produced by a radiology department and distributed through the medical director's office, in a top-down fashion, enabled a large, academic medical center to significantly reduce the number of unnecessary cervical spine radiographs (X-rays) in the emergency department, according to a study published in the July issue of the Journal of the American College of Radiology.

2 Jul 2010

Suggestions to reduce impact of anesthesia care on global warming

Inhaled anesthetics widely used for surgery—particularly the anesthetic desflurane—make a measurable contribution to global warming, according to a study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jul 2010

ISHLT issues first international consensus formulation of standardized nomenclature for CAV

Cardiac allograft vasculopathy (CAV), the major limitation to long term survival after heart transplantation, occurs when blood vessels in a transplanted heart progressively narrow and lead to dysfunction of the heart muscle or sudden death. Ascertaining benefit from appropriate treatment for this condition has been hampered in part because of the lack of a standard nomenclature.

2 Jul 2010

Medical Procedure News

BioMimetic reports final study results comparing Augment Bone Graft to autograft in foot, ankle fusion surgery

Review examines surgical and non-surgical treatments available for patients with knee arthritis

FDA issues formal response to Nephros' 510(k) application for hemodiafiltration system

Robots help remove diseased thyroid gland without neck incision

AUGIB patients more likely to suffer further bleeding with early red blood cell transfusion

Capstone Therapeutics to continue AZX100 Phase 2a trial in dermal scarring to planned 12-month endpoints

New Center for Image-Guided Intervention opened at MSKCC

Medicare reimbursement rates for outpatient repair of anal fistulas increased by 6%

Aastrom to pursue Phase 3 CLI clinical program through FDA SPA process

FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations

Hope for ovarian cancer patients not responding to conventional chemotherapy

AHRQ publishes new comparative effectiveness report on treatments for rotator cuff tears

Music therapy improves movement in stroke patients

First Australian intestinal transplant

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

Imaging algorithm distributed in top-down fashion reduces unnecessary cervical spine radiographs

Suggestions to reduce impact of anesthesia care on global warming

ISHLT issues first international consensus formulation of standardized nomenclature for CAV

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News